These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5119462)
1. [Clinical trials of a norgestrel-ethinyl estradiol combination sold under the name of Stediril]. Gaudefroy M; Corette L; Coliche D J Sci Med Lille; 1971; 89(8):333-48. PubMed ID: 5119462 [No Abstract] [Full Text] [Related]
2. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril]. Gaudefroy M; Corette L; Coliche D Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231 [No Abstract] [Full Text] [Related]
3. Triphasil--a new triphasic oral contraceptive. Med Lett Drugs Ther; 1985 May; 27(688):48. PubMed ID: 4000059 [No Abstract] [Full Text] [Related]
4. [Clinical and therapeutic study of a combination of ethinyl nortestosterone acetate and ethinyl estradiol]. Magnier P Gynecol Prat; 1968; 19(1):21-43. PubMed ID: 5748205 [No Abstract] [Full Text] [Related]
5. [Use of the preparation dl-13-ethyl-17-alpha-ethinyl-17-beta-hydroxy-4-gonen-3-on (WY 3707) in combination with ethinyl estradiol in gynecologic treatment and contraception]. Misinger I; Krobová I; Moravcová V Cesk Gynekol; 1968 Jun; 33(5):329-32. PubMed ID: 5662271 [No Abstract] [Full Text] [Related]
6. Fertility control with norgestrel and ethynil estradiol. Report on continuing studies. Rice-Wray E; Cervantes A; Garcilazo J; Valenzuela P J Reprod Med; 1972 Aug; 9(2):45-9. PubMed ID: 5050402 [No Abstract] [Full Text] [Related]
7. [Clinical use of Rigevidon, Ovidon and Postinor]. Serov VN; Glebova VV; Shakhova AD Akush Ginekol (Mosk); 1983 Nov; (11):17-9. PubMed ID: 6364871 [No Abstract] [Full Text] [Related]
8. Premenstrual syndrome and oral contraceptives of different character. Hetényi G Ther Hung; 1988; 36(4):170-3. PubMed ID: 3253960 [No Abstract] [Full Text] [Related]
10. [Biological and clinical data on a new estrolutein association]. Goisis M; Candotti G; Lami V Minerva Ginecol; 1967 Mar; 19(6):303-11. PubMed ID: 4971706 [No Abstract] [Full Text] [Related]
11. Observations with anteovin in family planning advisory unit. Domány Z Ther Hung; 1988; 36(1):29-33. PubMed ID: 3388289 [No Abstract] [Full Text] [Related]
12. [Combination of 17 alpha-ethinyl-trienolone (2 mg) and 17 alpha-ethinyl-estradiol (0,050 mg) in gynecologic therapy]. Soutoul JH Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(2):191-4. PubMed ID: 5758158 [No Abstract] [Full Text] [Related]
13. [A clinical study of the triphasic contraceptive Tri-Regol]. Rachev E Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433 [No Abstract] [Full Text] [Related]
14. Femodene/Minulet--how different is gestodene? Drug Ther Bull; 1990 May; 28(11):41-2. PubMed ID: 2131208 [No Abstract] [Full Text] [Related]
15. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles]. Lévrier M Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561 [No Abstract] [Full Text] [Related]
16. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
17. Letter: Norgestrel and acne. Med J Aust; 1971 Sep; 2(11):594. PubMed ID: 4272550 [No Abstract] [Full Text] [Related]
18. [Medical indications for the prescription of ovulation inhibitors in gynecologic practice]. Willmes HG Med Welt; 1969 Mar; 10():526-31. PubMed ID: 4239080 [No Abstract] [Full Text] [Related]